KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Income from Non-Controlling Interests (2016 - 2020)

Evolent Health (EVH) has 6 years of Income from Non-Controlling Interests data on record, last reported at $822000.0 in Q4 2020.

  • For Q4 2020, Income from Non-Controlling Interests rose 128.06% year-over-year to $822000.0; the TTM value through Sep 2020 reached -$3.8 million, down 47.79%, while the annual FY2020 figure was $822000.0, 122.78% up from the prior year.
  • Income from Non-Controlling Interests reached $822000.0 in Q4 2020 per EVH's latest filing, up from -$822000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $822000.0 in Q4 2020 and bottomed at -$51.1 million in Q1 2016.
  • Average Income from Non-Controlling Interests over 5 years is -$4.8 million, with a median of -$822000.0 recorded in 2020.
  • Peak YoY movement for Income from Non-Controlling Interests: plummeted 335.08% in 2019, then surged 128.06% in 2020.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$7.8 million in 2016, then soared by 91.9% to -$631000.0 in 2017, then soared by 80.03% to -$126000.0 in 2018, then crashed by 2224.6% to -$2.9 million in 2019, then soared by 128.06% to $822000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were $822000.0 in Q4 2020, -$822000.0 in Q3 2020, and -$2.9 million in Q4 2019.